ArticleJournal of medicinal chemistry2026
Structure-Activity Relationship Study of Protoberberine Alkaloids Reveals Molecular Planarity as a Key Determinant of Membrane Interaction and Protection from Misfolded Protein Oligomers.
Article in Journal of medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Interaction of berberine (Brb) with cell membranes is crucial for its bioavailability, blood-brain barrier permeation, and neuroprotection against misfolded protein oligomers in neurodegenerative diseases. Although Brb follows Lipinski's rule of five, the structural drivers of its membrane permeation remain unclear. We combined biophysical analyses on biomimetic liposomes with cell culture assays to evaluate eight natural protoberberine alkaloids (PBAs), assessing membrane interactions and protective effects. While traditional physicochemical descriptors varied minimally across the series, molecular planarity, quantified by non-hydrogen out-of-plane atoms, emerged as the key structural feature determining membrane binding affinity, kinetics, stiffening, and protein-oligomer displacement. These membrane effects correlated with the ability of the compounds to mitigate oligomer-induced calcium influx in cell cultures, an early cytotoxicity marker. ANS fluorescence and circular dichroism spectroscopy showed no direct oligomer-PBA interaction, ruling out this mechanism. These findings establish a rational framework for optimizing the Brb benzylisoquinoline scaffold, indicating that increasing molecular planarity enhances membrane affinity and neuroprotection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.